Propanc Biopharma focuses on the development of cancer treatments for patients with pancreatic, ovarian,and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.
